# Diabetes Research Hub — Iteration Run Report
**Date:** 2026-06-18 (Thursday) · Automated agent run

## Bottom line (the thing you don't want to hear first)
Git is **still blocked** and the backlog is growing — now **40 commits ahead of origin** plus uncommitted changes. This is the third+ consecutive run unable to push. The sandbox cannot fix it; it needs ~30 seconds from you. Everything else (vetting, validation, credibility, rebuild) is healthy. **[Certain]**

## Action required from you (1 minute)
A stale, empty `.git\index.lock` (dated Jun-17) is locking the OneDrive repo. The sandbox gets `Operation not permitted` trying to delete it. In PowerShell in `C:\Users\justi\OneDrive\Diabetes_Research`:

```powershell
del .git\index.lock
git add -A
git commit -m "Sync: gap audits + nutrition-beta promotion candidate (2026-06-18)"
git push
```

Until this runs, no agent work since ~Jun-13 is on GitHub. **[Certain]**

## What I did this run (3 substantive items + sweep + rebuild)

**1. Credibility sweep — CLEAN.** No fabricated PMIDs (>42M) in scripts, no "zero SAEs/zero rejection", no "curative/achieves cure" claims (the only hits are `verify_before_deploy.py`'s own flag-word regex). **[Certain]**

**2. Gap #5 — Islet Transplant × Drug Repurposing (SILVER) — audited, retain SILVER.**
Last audited 2026-04-21 (~2 months stale). The direct intersection I'm tracking — a *systematic GENERIC-drug repurposing screen with islet-transplant outcome endpoints* — is still ~0 papers. Adjacent activity is growing but doesn't fill it: the 2026 editorial *"Finding new hope in old treatments: repurposing immunotherapy in transplantation"* (PMC12698390) is review-level; tegoprubart (Eledon/UChicago, updated Mar 2026), felzartamab (anti-CD38, from myeloma), and off-label baricitinib are **biologics/branded, not generic small-molecule screens**. Novelty intact. **[Likely]** — to reach [Certain] I'd need a full PubMed/EMBASE intersection query, not a web sweep.

**3. Gap #13 — Personalized Nutrition for Beta Cells — SECOND INDEPENDENT SOURCE CONFIRMED.**
This is the high-value find. Two independent sources, both **verified against NCBI** (not asserted):
- **PMID 39634180** — digital-twin personalized-nutrition RCT, *Front Endocrinol* 2024; reports enhanced **beta-cell function** + hyperinsulinemia normalization + T2D remission.
- **PMID 40982327** — *Type 2 Diabetes Remission: SR & Meta-analysis of Nonsurgical RCTs*, **Diabetes Care 2025 Dec** (top-tier, independent).

Caveat I'm not hiding: 40982327 is nutrition→remission *broadly*, not "personalized"-specific — the personalized + beta-cell specificity still rests mainly on 39634180. The gap is **narrowing**, and it now clears the bar for **BRONZE→SILVER promotion** (marked `promotion_candidate=True`). **[Certain]** on the two sources being real; **[Likely]** that the gap is genuinely closing.

**4. Rebuild pipeline — all 41 stages [OK].** `run_quality_improvements.py` completed cleanly. **[Certain]**

## Two state-integrity issues I found and one I fixed
- **Tier mismatch (flagged, not auto-resolved):** `agent_state.json` lists Gap #13 as **SILVER**, but `build_nutrition_beta.py` / the dashboard still label it **BRONZE**. The two systems also number gaps differently (state Gap #5 = Islet×Repurposing; dashboard Gap #5 = Treg in Neuropathy). I queued a reconciliation task rather than silently editing the build script. **[Certain]**
- **Duplicate path key (fixed):** `validated_paths['dapagliflozin_nephropathy']` had no verdict; it's a duplicate of the VALIDATED `dapagliflozin -> nephropathy` (DAPA-CKD, PMID 32862232/35364937). Reconciled to VALIDATED with a note. **[Certain]**
- **Note on the "38 unvalidated paths" figure** from earlier runs: misleading. Most store their verdict under the `rating` key, not `status`. True unvalidated count was **1**. **[Certain]**

## Corpus health
285 papers, all VETTED (272 clean, 13 legitimately FLAGGED as off-topic). No vetting backlog. 56/57 paths carry a validation verdict.

## Skipped (by design)
Weekly new-paper PubMed sweep — runs Mondays only; today is Thursday.

## Queue after this run
23 items. Highest priority remains the **git unblock (manual, you)**. Next gap audits cluster ~2026-06-27 to 07-18; Gap #13 tier reconciliation queued at priority 4.

---
*Sources consulted this run:*
- Diabetes Care 2025 SR/MA — https://pubmed.ncbi.nlm.nih.gov/40982327/
- Digital-twin nutrition RCT — https://pubmed.ncbi.nlm.nih.gov/39634180/
- Repurposing immunotherapy in transplantation (editorial) — https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12698390/
- Eledon tegoprubart islet trial update — https://ir.eledon.com/news-releases/news-release-details/eledon-announces-updated-data-investigator-initiated-islet
